Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Ototoxicity 3Mesothelioma, Malignant 3Liver Neoplasms 2Hepatoblastoma 2Testicular Neoplasms 1Teratoma 1Stomach Neoplasms 1Sarcoma 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Mouth Neoplasms 1Mesothelioma 1Medulloblastoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hyperthermia 1Hearing Loss 1Glioma 1Gastrointestinal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma 1Brain Neoplasms 1Astrocytoma 1Adrenocortical Carcinoma 1Adenocarcinoma 1

Interventions

sodium thiosulfate 1ebselen 1Tomography, X-Ray Computed 1Sodium Chloride 1Magnetic Resonance Imaging 1Hyaluronic Acid 1Hearing Tests 1Genetic Association Studies 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hearing Loss × sodium thiosulfate × Clear all
NCT04262336 2023-07-06

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Decibel Therapeutics

Phase 1 Completed
22 enrolled

Ototoxicity, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡